Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 Neoplasms 3 Lung Neoplasms 2 Uterine Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Sarcoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pleural Effusion 1 Pituitary Diseases 1 Pituitary ACTH Hypersecretion 1 Obesity 1 Myasthenia Gravis 1 Motor Activity 1 Lymphoma 1 Kidney Neoplasms 1 Endometrial Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Advanced Solid Tumors 1 Adenocarcinoma of Lung 1 ACTH-Secreting Pituitary Adenoma 1

Interventions

Paclitaxel 42 Carboplatin 35 pembrolizumab 25 Surveys and Questionnaires 23 Letrozole 15 Radiotherapy 14 Megestrol Acetate 14 Blood Specimen Collection 14 Bevacizumab 13 olaparib 12 Metformin 12 dostarlimab 10 Indocyanine Green 10 durvalumab 9 Observation 9 Medroxyprogesterone Acetate 9 Cisplatin 9 lenvatinib 8 atezolizumab 8 Early Intervention, Educational 8 Counseling 8 niraparib 7 Sentinel Lymph Node Biopsy 7 Radiation 7 Methods 7 Magnetic Resonance Spectroscopy 7 Lymph Node Excision 7 Hysterectomy 7 Everolimus 7 abemaciclib 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Endometrial Neoplasms × Biomarkers × Clear all

NCT02543710 2017-03-28

Momatec2

Haukeland University Hospital

Phase 4 Recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡